| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 273,1 k € | -0.2% | 273,7 k € | +1.9% | 268,7 k € | -2.6% | 275,8 k € | ||||||||||||||||
| Gross margin | 274,0 k € | -5.7% | 290,7 k € | +172.3% | 106,8 k € | +65.4% | 64,6 k € | -1.7% | 65,7 k € | -3.1% | 67,8 k € | +32.7% | 51,1 k € | -16.0% | 60,8 k € | +2.6% | 59,3 k € | -12.8% | 68,0 k € | -20.8% | 85,8 k € | +2.7% | 83,6 k € | -24.1% | 110,1 k € | +102.2% | 54,4 k € | -44.6% | 98,2 k € | -18.4% | 120,4 k € | -8.2% | 131,2 k € | +154.1% | 51,6 k € | -64.2% | 144,4 k € | |
| EBITDA | 274,0 k € | -5.7% | 290,7 k € | +196.4% | 98,1 k € | +71.8% | 57,1 k € | +0.3% | 56,9 k € | -3.6% | 59,1 k € | +39.1% | 42,5 k € | -22.9% | 55,1 k € | -1.9% | 56,2 k € | -13.6% | 65,1 k € | -21.6% | 82,9 k € | +2.8% | 80,7 k € | -24.7% | 107,1 k € | +107.5% | 51,6 k € | -43.3% | 91,1 k € | -10.7% | 102,1 k € | -0.8% | 102,9 k € | +162.6% | 39,2 k € | -72.3% | 141,2 k € | |
| Operating profit | 233,1 k € | -12.7% | 266,9 k € | +313.2% | 64,6 k € | +153.0% | 25,5 k € | +6.6% | 24,0 k € | -6.6% | 25,7 k € | +197.8% | 8,6 k € | -66.6% | 25,8 k € | -28.7% | 36,2 k € | -18.3% | 44,3 k € | -28.5% | 61,9 k € | +45.3% | 42,6 k € | -38.1% | 68,8 k € | +637.3% | 9,3 k € | -82.1% | 52,2 k € | +60.7% | 32,5 k € | -23.9% | 42,7 k € | +244.2% | -29,6 k € | -137.1% | 79,8 k € | |
| Profit/loss | 162,0 k € | -11.0% | 182,0 k € | +334.4% | 41,9 k € | +215.5% | 13,3 k € | +1.3% | 13,1 k € | -15.6% | 15,5 k € | +1477.1% | 985,5 € | -94.5% | 18,0 k € | -26.1% | 24,3 k € | -3.4% | 25,2 k € | -36.9% | 39,9 k € | +49.5% | 26,7 k € | -43.1% | 47,0 k € | +859.0% | 4,9 k € | -86.5% | 36,2 k € | +141.4% | 15,0 k € | -57.4% | 35,2 k € | +214.9% | -30,7 k € | -160.8% | 50,4 k € | |
| Equity | 590,0 k € | +37.6% | 428,8 k € | +60.3% | 267,6 k € | +18.2% | 226,5 k € | -27.9% | 314,0 k € | +4.1% | 301,7 k € | +5.1% | 286,9 k € | +0.1% | 286,7 k € | +1.3% | 283,1 k € | +0.1% | 282,7 k € | +9.8% | 257,5 k € | +11.7% | 230,6 k € | -18.8% | 284,1 k € | +19.8% | 237,1 k € | +2.1% | 232,2 k € | +18.5% | 196,0 k € | +8.3% | 181,0 k € | -26.4% | 245,8 k € | -11.1% | 276,4 k € | |
| Total assets | 672,5 k € | +31.6% | 511,0 k € | +68.9% | 302,6 k € | -13.9% | 351,4 k € | +0.2% | 350,8 k € | -5.9% | 373,0 k € | +4.7% | 356,2 k € | -3.7% | 369,8 k € | +14.7% | 322,5 k € | +11.7% | 288,8 k € | +5.9% | 272,7 k € | -0.7% | 274,6 k € | -18.7% | 337,7 k € | +2.6% | 329,2 k € | -9.8% | 365,0 k € | -14.0% | 424,5 k € | +25.5% | 338,3 k € | -21.3% | 430,2 k € | -8.8% | 471,6 k € | |
| Cash | 396,4 k € | +87.1% | 211,8 k € | +152.0% | 84,1 k € | -54.3% | 184,1 k € | +15.8% | 159,0 k € | +7.4% | 148,1 k € | +44.2% | 102,7 k € | -30.6% | 148,0 k € | -26.0% | 200,1 k € | +92.8% | 103,8 k € | +49.3% | 69,5 k € | +9.5% | 63,5 k € | -35.2% | 98,0 k € | +24.6% | 78,7 k € | -29.1% | 111,0 k € | +73.6% | 63,9 k € | +103.6% | 31,4 k € | -73.9% | 120,4 k € | -27.1% | 165,2 k € | |
| Debts | 78,9 k € | -4.1% | 82,3 k € | +134.9% | 35,0 k € | -72.0% | 125,0 k € | +239.4% | 36,8 k € | -48.4% | 71,3 k € | +2.9% | 69,3 k € | -16.6% | 83,1 k € | +110.5% | 39,5 k € | +549.4% | 6,1 k € | -60.1% | 15,2 k € | -65.4% | 44,1 k € | -17.8% | 53,6 k € | -41.8% | 92,1 k € | -30.6% | 132,8 k € | -41.9% | 228,5 k € | +45.2% | 157,3 k € | -14.7% | 184,4 k € | -5.5% | 195,1 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0,4 | 0,6 | 0,2 | — | |||||||||||||||||||
Private limited company · Mons · incorporated on 18/01/2000
Private limited company profitable and well capitalised. Cash position rising (+87.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. YANNI is a Private limited company incorporated in 2000. Its main activity is: Specialist medical practice activities. Its registered office is in Mons.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette